Dr. Drappatz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
# Upmc
Pittsburgh, PA 15232Phone+1 412-623-7955
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuro-Oncology, 2004 - 2005- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2001 - 2004
Boston University Medical CenterInternship, Internal Medicine, 2000 - 2001
Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1999
Certifications & Licensure
PA State Medical License 2011 - 2024
MA State Medical License 2004 - 2012- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Member Best Doctors
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Gliomas Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 398 citationsPhase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent GlioblastomaTracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott R. Plotkin
Journal of Clinical Oncology. 2010-06-10 - 50 citationsIndividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Gliobl...Brian M. Alexander, Lorenzo Trippa, Sarah C. Gaffey, Isabel Arrillaga-Romany, Eudocia Q. Lee
JCO Precision Oncology. 2019-03-27 - 1364 citationsAZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsTracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso, Wei Ting Zhang, Dan G. Duda
Cancer Cell. 2007-01-01
Other
- Seizures in patients with primary and metastatic brain tumorsDrappatz J, Avila EK, Wen PY
http://www.uptodate.com/contents/seizures-in-patients-with-primary-and-metastatic-brain-tumors
UpToDate, Wolters Kluwer Health - 2013-04-03 - Management of vasogenic edema in patients with primary and metastatic brain tumorsDrappatz J, Wen PY
http://www.uptodate.com/contents/management-of-vasogenic-edema-in-patients-with-primary-and-metastat
UpToDate, Wolters Kluwer Health - 2013-02-13 - Systemic therapy for brain metastasesDrappatz J, Wen PY
http://www.uptodate.com/contents/systemic-therapy-for-brain-metastases
UpToDate, Wolters Kluwer Health - 2012-12-07
Press Mentions
Benefits of WBRT for Brain MetastasesAugust 2nd, 2019
New Molecule Found to Cross the Blood‐Brain Barrier: Reporte... : Neurology TodayFebruary 28th, 2017
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
